Clinical trial
EWO1 in Persistent Allergic Rhinitis Patients
NCT00153595 · China Medical University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00153595 |
|---|---|
| Title | EWO1 in Persistent Allergic Rhinitis Patients |
| Official title | A Double-Blind, Randomized Parallel Group, Placebo-Control Study of EW01 in Persistent Allergic Rhinitis (PAR) Patients |
| Lead sponsor | China Medical University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | EWO1 |
| Enrollment | 60 |
| Start date | Nov 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 25, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: